Outpatient anticoagulant therapy may cut COVID-19 admission risk
(HealthDay)—Individuals using anticoagulation therapy on an outpatient basis who are diagnosed with COVID-19 have a reduced risk for hospital admission, according to a study published online Sept. 24 in EClinicalMedicine.